By Buy This GLP Editorial Team · Editorial profile: Wesley Jenkins
NextMeds review
Featured $49 offer
The public offer gives a starting amount without a named medication or established refill total.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
NextMeds advertises weight management from $49 per month and says the featured price stays the same each month. The public page does not establish that price for both compounded medications.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
What the figure does not cover
Fees, terms and cancellation at NextMeds
- Cancellation
- Check the offer available to you for product availability, the processing date and cancellation or refund terms.
Pricing transparency
How NextMeds publishes its prices
When you compare the advertised price with the renewal bill, confirm the exact medication and what the featured offer includes. The published starting and follow-up prices in the Rx.com review show why you need both numbers. NextMeds lists multiple compounded treatment options, but does not publish a separate verifiable current tirzepatide renewal price.
At a glance
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What NextMeds is
NextMeds advertises several compounded weight-management options under one general offer.
How it works
Ask which medicine and services are included before using the featured price to budget for treatment.
Branded or compounded
Compounded medications are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality.
Where the money holds, and where it moves
Predictable
- Publishes information about its weight-management offers
Moves, or is not stated
- Eligibility and plan terms affect the offer available to you
Who this is worth it for
People who can request an itemized quote for the prescribed plan.
Who should price elsewhere
People who need fixed published prices for both medications.
The molecules
What NextMeds prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside NextMeds
KERNX HealthPeople comparing standard doses who want an advertised rate that stays flat across doses.
See KERNX Health →
LibertyPeople who can confirm their selected plan’s actual price.
See Liberty →
Peak WellnessPeople who want published regular rates and shipping included.
See Peak Wellness →
More GLP-1 sellers by price priced end to end: EmbraceRXeMedEnara HealthEnhancedEverFit MedicalEvergreen Telehealth
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Does the $49 offer show a specific refill cost?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare NextMeds against every seller on it.